Lipoxin A4 Preconditioning Attenuates Intestinal Ischemia Reperfusion Injury through Keap1/Nrf2 Pathway in a Lipoxin A4 Receptor Independent Manner

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Han, Xue ^a   Yao, Weifeng ^b   Liu, Zipeng ^c   Li, Haobo ^c   Zhang, Zhong Jun ^d   Hei, Ziqing ^b   Xia, Zhengyuan ^c,e  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d SHENZHEN PEOPLE'S HOSPITAL   (China)

^e GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; CELL DEATH; CHEMICAL ACTIVATION; ENZYMES; FATTY ACIDS; LACTIC ACID; OXIDATIVE STRESS; OXYGEN; RATS;

FATTY ACID-BINDING PROTEINS; INTESTINAL EPITHELIUM; INTESTINAL ISCHEMIA; OXIDATIVE STRESS MARKERS; POTENT ANTIOXIDANTS; POTENTIAL MECHANISM; RECEPTOR ANTAGONISTS; SUPEROXIDE DISMUTASE ACTIVITIES;

IIR FILTERS;

AMINE OXIDASE (COPPER CONTAINING); BRUSATOL; FATTY ACID BINDING PROTEIN; FORMYLPEPTIDE RECEPTOR LIKE 1; ISOPROSTANE DERIVATIVE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; LACTIC ACID; LIPOXIN A; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; 15-F2T-ISOPROSTANE; ANTIOXIDANT; LIPOXIN; LIPOXIN A(4) RECEPTOR, RAT; LIPOXIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; REOXYGENATION; REPERFUSION INJURY; SURVIVAL RATE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENETICS; INTESTINE; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; INTESTINES; ISOPROSTANES; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; LACTIC ACID; LIPOXINS; MALE; MICROSCOPY, FLUORESCENCE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LIPOXIN; REPERFUSION INJURY; RNA INTERFERENCE; RNA, SMALL INTERFERING; SUPEROXIDE DISMUTASE;

EID: 84976384379     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/9303606     Document Type: Article

References (43)

1. D. G. Farmer, R. S. Venick, J. Colangelo et al., "Pretransplant predictors of survival after intestinal transplantation: Analysis of a single-center experience of more than 100 transplants, " Transplantation, vol. 90, no. 12, pp. 1574-1580, 2010.
2. M. Vincenti, M. Behrends, K. Dang et al., "Induction of intestinal ischemia reperfusion injury by portal vein outflowocclusion in rats, " Journal of Gastroenterology, vol. 45, no. 11, pp. 1103-1110, 2010.
3. M. E. Diebel, L.N. Diebel, C.W. Manke, D.M. Liberati, and J. R. Whittaker, "Early tranexamic acid administration: A protective effect on gut barrier function following ischemia/reperfusion injury, " The Journal of Trauma and Acute Care Surgery, vol. 79, no. 6, pp. 1015-1022, 2015.
4. Y. Chen, V.C.H. Lui, N.V. Rooijen, andP. K.H. Tam, "Depletion of intestinal resident macrophages prevents ischaemia reperfusion injury in gut, " Gut, vol. 53, no. 12, pp. 1772-1780, 2004.
5. B. Martin, "Prevention of gastrointestinal complications in the critically ill patient, " AACN Advanced Critical Care, vol. 18, no. 2, pp. 158-166, 2007.
6. F. J. Akinrinmade, A. S. Akinrinde, O. O. Soyemi, and A. A. Oyagbemi, "Antioxidant potential of the methanol extract of Parquetina nigrescens mediates protection against intestinal ischemia-reperfusion injury in rats, " Journal of Dietary Supplements, vol. 13, no. 4, pp. 420-432, 2016.
7. O. Onal, F. Yetisir, A. E. S. Sarer et al., "Prophylactic ozone administration reduces intestinal mucosa injury induced by intestinal ischemia-reperfusion in the rat, " Mediators of Inflammation, vol. 2015, Article ID 792016, 8 pages, 2015.
8. W. Zhao, S. Zhou, W. Yao et al., "Propofol prevents lung injury after intestinal ischemia-reperfusion by inhibiting the interaction between mast cell activation and oxidative stress, " Life Sciences, vol. 108, no. 2, pp. 80-87, 2014.
9. L. M. Aleksunes and J. E. Manautou, "Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease, " Toxicologic Pathology, vol. 35, no. 4, pp. 459-473, 2007.
10. T. Nguyen, P. Nioi, and C. B. Pickett, "The Nrf2-Antioxidant response element signaling pathway and its activation by oxidative stress, " The Journal of Biological Chemistry, vol. 284, no. 20, pp. 13291-13295, 2009.
11. M. Ge, X. Chi, A. Zhang et al., "IntestinalNF-E2-related factor-2 expression and antioxidant activity changes in rats undergoing orthotopic liver autotransplantation, " Oncology Letters, vol. 6, no. 5, pp. 1307-1312, 2013.
12. J. A. Chandrasekharan and N. Sharma-Wali, "Lipoxins: nature's way to resolve inflammation, " Journal of Inflammation Research, vol. 8, pp. 181-192, 2015.
13. P. Maderna and C. Godson, "Lipoxins: resolutionary road, " British Journal of Pharmacology, vol. 158, no. 4, pp. 947-959, 2009.
14. C. F. Wenceslau, C. G. Mccarthy, T. Szasz, and R. C. Webb, "Lipoxin A4 mediates aortic contraction via rhoa/rho kinase, endothelial dysfunction and reactive oxygen species, " Journal of Vascular Research, vol. 51, no. 6, pp. 407-417, 2014.
15. Y. Wu, H. Zhai, Y. Wang et al., "Aspirin-Triggered lipoxin A4 attenuates lipopolysaccharide-induced intracellular ROS in BV2 microglia cells by inhibiting the function of NADPH oxidase, " Neurochemical Research, vol. 37, no. 8, pp. 1690-1696, 2012.
16. E. Börgeson, J. Lönn, I. Bergström et al., "Lipoxin A4 inhibits Porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression, " Infection and Immunity, vol. 79, no. 4, pp. 1489-1497, 2011.
17. L. Zong, J. Li, X. Chen et al., "LipoxinA4 attenuates cell invasion by inhibiting ROS/ERK/MMP pathway in pancreatic cancer, " OxidativeMedicine and Cellular Longevity, vol. 2016, Article ID 6815727, 9 pages, 2016.
18. N. Chiang, C. N. Serhan, S.-E. Dahĺen et al., "The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo, " Pharmacological Reviews, vol. 58, no. 3, pp. 463-487, 2006.
19. M. Sobrado, M. P. Pereira, I. Ballesteros et al., "Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke, " The Journal of Neuroscience, vol. 29, no. 12, pp. 3875-3884, 2009.
20. X. Chi, W. Yao, H. Xia et al., "Elevation of HO-1 expression mitigates intestinal ischemia-reperfusion injury and restores tight junction function in a rat liver transplantation model, " Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 986075, 12 pages, 2015.
21. Y. Qiao, J. Qian, Q. Lu, Y. Tian, Q. Chen, andY. Zhang, "Protective effects of butyrate on intestinal ischemia-reperfusion injury in rats, "The Journal of Surgical Research, vol. 197, no. 2, pp. 324-330, 2015.
22. Z. Chen, Z. Wu, C. Huang et al., "Effect of lipoxin A4 onmyocardial ischemia reperfusion injury following cardiac arrest in a rabbit model, " Inflammation, vol. 36, no. 2, pp. 468-475, 2013.
23. J. Gong, S. Guo, H.-B. Li, S.-Y. Yuan, Y. Shang, and S.-L. Yao, "BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats, " Resuscitation, vol. 83, no. 7, pp. 907-912, 2012.
24. D. Ren, N. F. Villeneuve, T. Jiang et al., "Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 4, pp. 1433-1438, 2011.
25. C. J. Chiu, A. H. McArdle, R. Brown, H. J. Scott, and F.N. Gurd, "Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal, " Archives of Surgery, vol. 101, no. 4, pp. 478-483, 1970.
26. C. Luo, D. Yuan, W. Yao et al., "Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells, " Life Sciences, vol. 122, pp. 72-77, 2015.
27. X.-Q. Chen, S.-H. Wu, Y. Zhou, and Y.-R. Tang, "Involvement of K+ channel-dependant pathways in lipoxin A4-induced protective effects on hypoxia/reoxygenation injury of cardiomyocytes, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 88, no. 5, pp. 391-397, 2013.
28. H. Li, W. Yao, Z. Liu et al., "Hyperglycemia abrogates ischemic postconditioning cardioprotection by impairing AdipoR1/Caveolin-3/STAT3 signaling in diabetic rats, " Diabetes, vol. 65, no. 4, pp. 942-955, 2016.
29. H. Li, W. Yao, M. G. Irwin et al., "Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activatingNrf2 andBrg1, " Free Radical Biology &Medicine, vol. 84, pp. 311-321, 2015.
30. W. Yao, G. Luo, G. Zhu et al., "Propofol activation of the Nrf2 pathway is associated with amelioration of acute lung injury in a rat liver transplantation model, " Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 258567, 9 pages, 2014.
31. L. M. Gonzalez, A. J. Moeser, andA. T. Blikslager, "Animal models of ischemia-reperfusion-induced intestinal injury: progress and promise for translational research, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 308, no. 2, pp. G63-G75, 2015.
32. C. Liu, C. Zhu, G. Wang, R. Xu, and Y. Zhu, "Higenamine regulatesNrf2-HO-1-Hmgb1 axis and attenuates intestinal ischemiareperfusion injury in mice, " Inflammation Research, vol. 64, no. 6, pp. 395-403, 2015.
33. G. Bannenberg, R.-L. Moussignac, K. Gronert et al., "Lipoxins and novel 15-epi-lipoxin analogs display potent antiinflammatory actions after oral administration, " British Journal of Pharmacology, vol. 143, no. 1, pp. 43-52, 2004.
34. Y.-P. Sun, E. Tjonahen, R. Keledjian et al., "Anti-inflammatory and pro-resolving properties of benzo-lipoxin A4 analogs, " Prostaglandins Leukotrienes and Essential FattyAcids, vol. 81, no. 5-6, pp. 357-366, 2009.
35. Y. Wu, Y.-P. Wang, P. Guo et al., "A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury, " Journal of Molecular Neuroscience, vol. 46, no. 3, pp. 483-491, 2012.
36. H.-B. Li, G.-Z. Wang, J. Gong et al., "BML-111 attenuates hemorrhagic shock-induced acute lung injury through inhibiting activation of mitogen-Activated protein kinase pathway in rats, " The Journal of Surgical Research, vol. 183, no. 2, pp. 710-719, 2013.
37. M. Tang, L. Chen, B. Li et al., "BML-111 attenuates acute lung injury in endotoxemic mice, " The Journal of Surgical Research, vol. 200, no. 2, pp. 619-630, 2016.
38. L. Wu, H.-H. Li, Q. Wu et al., "LipoxinA4 activatesNrf2 pathway and ameliorates cell damage in cultured cortical astrocytes exposed to oxygen-glucose deprivation/reperfusion insults, " Journal of Molecular Neuroscience, vol. 56, no. 4, pp. 848-857, 2015.
39. M. A. O'Connell and J. D. Hayes, "The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic, " Biochemical Society Transactions, vol. 43, pp. 687-689, 2015.
40. T. Satoh, S. R. McKercher, and S. A. Lipton, "Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs, " Free Radical Biology & Medicine, vol. 65, pp. 645-657, 2013.
41. H. Hao, F. Xu, J. Hao et al., "Lipoxin A4 suppresses lipopolysaccharide-induced hela cell proliferation and migration via NFkappaB pathway, " Inflammation, vol. 38, pp. 400-408, 2015.
42. Q. Zhao, L. Shao, X. Hu et al., "LipoxinA4 preconditioning and postconditioning protect myocardial ischemia/reperfusion injury in rats, " Mediators of Inflammation, vol. 2013, Article ID 231351, 13 pages, 2013.
43. R. Wu, W. Zhou, S. Chen et al., "Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway, " British Journal of Pharmacology, vol. 171, no. 21, pp. 4927-4940, 2014.